ArticleEndocrine, metabolic & immune disorders drug targets2025

Empagliflozin and Arterial Stiffness in Patients with Type 2 Diabetes: A Real-World Case-Control Study.

Francesco Tassone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.